mark thompson lifesciences ltd.
mark thompson lifesciences ltd. Company Information
Company Number
09507173
Next Accounts
Dec 2025
Shareholders
mark thompson
joanne thompson
Group Structure
View All
Industry
Management consultancy activities (other than financial management)
Registered Address
unit 23-25 innovation house, south church enterprise park, bishop auckland, co. durham, DL14 6XB
Website
markthompsonls.commark thompson lifesciences ltd. Estimated Valuation
Pomanda estimates the enterprise value of MARK THOMPSON LIFESCIENCES LTD. at £216k based on a Turnover of £407.6k and 0.53x industry multiple (adjusted for size and gross margin).
mark thompson lifesciences ltd. Estimated Valuation
Pomanda estimates the enterprise value of MARK THOMPSON LIFESCIENCES LTD. at £626.9k based on an EBITDA of £146.7k and a 4.27x industry multiple (adjusted for size and gross margin).
mark thompson lifesciences ltd. Estimated Valuation
Pomanda estimates the enterprise value of MARK THOMPSON LIFESCIENCES LTD. at £758.5k based on Net Assets of £284.7k and 2.66x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Mark Thompson Lifesciences Ltd. Overview
Mark Thompson Lifesciences Ltd. is a live company located in bishop auckland, DL14 6XB with a Companies House number of 09507173. It operates in the management consultancy activities other than financial management sector, SIC Code 70229. Founded in March 2015, it's largest shareholder is mark thompson with a 67% stake. Mark Thompson Lifesciences Ltd. is a established, micro sized company, Pomanda has estimated its turnover at £407.6k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Mark Thompson Lifesciences Ltd. Health Check
Pomanda's financial health check has awarded Mark Thompson Lifesciences Ltd. a 4 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 4 areas for improvement. Company Health Check FAQs
2 Strong
5 Regular
4 Weak
Size
annual sales of £407.6k, make it in line with the average company (£429.5k)
- Mark Thompson Lifesciences Ltd.
£429.5k - Industry AVG
Growth
3 year (CAGR) sales growth of -28%, show it is growing at a slower rate (10.5%)
- Mark Thompson Lifesciences Ltd.
10.5% - Industry AVG
Production
with a gross margin of 58.4%, this company has a comparable cost of product (58.4%)
- Mark Thompson Lifesciences Ltd.
58.4% - Industry AVG
Profitability
an operating margin of 32.5% make it more profitable than the average company (8.5%)
- Mark Thompson Lifesciences Ltd.
8.5% - Industry AVG
Employees
with 4 employees, this is similar to the industry average (4)
4 - Mark Thompson Lifesciences Ltd.
4 - Industry AVG
Pay Structure
on an average salary of £49k, the company has an equivalent pay structure (£49k)
- Mark Thompson Lifesciences Ltd.
£49k - Industry AVG
Efficiency
resulting in sales per employee of £101.9k, this is equally as efficient (£116.8k)
- Mark Thompson Lifesciences Ltd.
£116.8k - Industry AVG
Debtor Days
it gets paid by customers after 81 days, this is later than average (63 days)
- Mark Thompson Lifesciences Ltd.
63 days - Industry AVG
Creditor Days
its suppliers are paid after 0 days, this is quicker than average (25 days)
- Mark Thompson Lifesciences Ltd.
25 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Mark Thompson Lifesciences Ltd.
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (27 weeks)
0 weeks - Mark Thompson Lifesciences Ltd.
27 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 45.1%, this is a lower level of debt than the average (52.4%)
45.1% - Mark Thompson Lifesciences Ltd.
52.4% - Industry AVG
MARK THOMPSON LIFESCIENCES LTD. financials
Mark Thompson Lifesciences Ltd.'s latest turnover from March 2024 is estimated at £407.6 thousand and the company has net assets of £284.7 thousand. According to their latest financial statements, Mark Thompson Lifesciences Ltd. has 4 employees and maintains cash reserves of £3.2 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||
| Other Income Or Grants | |||||||||
| Cost Of Sales | |||||||||
| Gross Profit | |||||||||
| Admin Expenses | |||||||||
| Operating Profit | |||||||||
| Interest Payable | |||||||||
| Interest Receivable | |||||||||
| Pre-Tax Profit | |||||||||
| Tax | |||||||||
| Profit After Tax | |||||||||
| Dividends Paid | |||||||||
| Retained Profit | |||||||||
| Employee Costs | |||||||||
| Number Of Employees | 4 | 4 | 4 | 4 | 4 | 5 | 4 | ||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 60,005 | 79,989 | 63,928 | 78,228 | 34,051 | 16,913 | 15,529 | 20,190 | 16,992 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 60,005 | 79,989 | 63,928 | 78,228 | 34,051 | 16,913 | 15,529 | 20,190 | 16,992 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 90,610 | 153,485 | 145,554 | 305,754 | 154,832 | 202,399 | 163,055 | 177,083 | 39,181 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 365,030 | 284,343 | 214,072 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 3,216 | 236 | 6,242 | 0 | 0 | 0 | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 458,856 | 438,064 | 365,868 | 305,754 | 154,832 | 202,399 | 163,055 | 177,083 | 39,181 |
| total assets | 518,861 | 518,053 | 429,796 | 383,982 | 188,883 | 219,312 | 178,584 | 197,273 | 56,173 |
| Bank overdraft | 10,000 | 10,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 269 | 2,517 | 30,422 | 150,410 | 94,847 | 120,273 | 69,122 | 68,456 | 55,694 |
| Group/Directors Accounts | 0 | 76,632 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 201,373 | 185,297 | 141,121 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 211,642 | 274,446 | 171,543 | 150,410 | 94,847 | 120,273 | 69,122 | 68,456 | 55,694 |
| loans | 11,640 | 21,640 | 41,640 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 10,845 | 31,593 | 0 | 49,167 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 2,694 | 3,879 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 22,485 | 55,927 | 45,519 | 49,167 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 234,127 | 330,373 | 217,062 | 199,577 | 94,847 | 120,273 | 69,122 | 68,456 | 55,694 |
| net assets | 284,734 | 187,680 | 212,734 | 184,405 | 94,036 | 99,039 | 109,462 | 128,817 | 479 |
| total shareholders funds | 284,734 | 187,680 | 212,734 | 184,405 | 94,036 | 99,039 | 109,462 | 128,817 | 479 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||
| Operating Profit | |||||||||
| Depreciation | 14,342 | 20,364 | 0 | ||||||
| Amortisation | 0 | 0 | 0 | ||||||
| Tax | |||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 17,812 | 78,202 | 53,872 | 150,922 | -47,567 | 39,344 | -14,028 | 137,902 | 39,181 |
| Creditors | -2,248 | -27,905 | -119,988 | 55,563 | -25,426 | 51,151 | 666 | 12,762 | 55,694 |
| Accruals and Deferred Income | 16,076 | 44,176 | 141,121 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | -2,694 | -1,185 | 3,879 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||||||
| Investing Activities | |||||||||
| capital expenditure | |||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||||
| Financing Activities | |||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | -76,632 | 76,632 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | -10,000 | -20,000 | 41,640 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | -20,748 | 31,593 | -49,167 | 49,167 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||
| interest | |||||||||
| cash flow from financing | |||||||||
| cash and cash equivalents | |||||||||
| cash | 2,980 | -6,006 | 6,242 | 0 | 0 | 0 | 0 | 0 | 0 |
| overdraft | 0 | 10,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 2,980 | -16,006 | 6,242 | 0 | 0 | 0 | 0 | 0 | 0 |
mark thompson lifesciences ltd. Credit Report and Business Information
Mark Thompson Lifesciences Ltd. Competitor Analysis
Perform a competitor analysis for mark thompson lifesciences ltd. by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other micro companies, companies in DL14 area or any other competitors across 12 key performance metrics.
mark thompson lifesciences ltd. Ownership
MARK THOMPSON LIFESCIENCES LTD. group structure
Mark Thompson Lifesciences Ltd. has no subsidiary companies.
Ultimate parent company
MARK THOMPSON LIFESCIENCES LTD.
09507173
mark thompson lifesciences ltd. directors
Mark Thompson Lifesciences Ltd. currently has 5 directors. The longest serving directors include Mr Mark Thompson (Mar 2015) and Mr Mark Thompson (Mar 2015).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Mark Thompson | 61 years | Mar 2015 | - | Director | |
| Mr Mark Thompson | England | 61 years | Mar 2015 | - | Director |
| Ms Britt Schuurs | England | 36 years | Oct 2024 | - | Director |
| Mr Milan Portengen | England | 35 years | Oct 2024 | - | Director |
| Mr Vincent Bremmer | Netherlands | 50 years | Oct 2024 | - | Director |
P&L
March 2024turnover
407.6k
-27%
operating profit
132.3k
0%
gross margin
58.4%
+1.04%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
284.7k
+0.52%
total assets
518.9k
0%
cash
3.2k
+12.63%
net assets
Total assets minus all liabilities
mark thompson lifesciences ltd. company details
company number
09507173
Type
Private limited with Share Capital
industry
70229 - Management consultancy activities (other than financial management)
incorporation date
March 2015
age
10
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
March 2024
previous names
mark thomspon lifesciences limited (March 2015)
accountant
MOMENTUM TAXATION AND ACCOUNTANCY LTD
auditor
-
address
unit 23-25 innovation house, south church enterprise park, bishop auckland, co. durham, DL14 6XB
Bank
-
Legal Advisor
-
mark thompson lifesciences ltd. Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to mark thompson lifesciences ltd..
mark thompson lifesciences ltd. Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for MARK THOMPSON LIFESCIENCES LTD.. This can take several minutes, an email will notify you when this has completed.
mark thompson lifesciences ltd. Companies House Filings - See Documents
| date | description | view/download |
|---|
